Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Life360, Inc. Director's Dealing 2025

Sep 3, 2025

30724_rns_2025-09-03_6db6e77b-0d00-4abc-a7f5-dc3f06e96e21.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

==> picture [11 x 11] intentionally omitted <==

==> picture [11 x 11] intentionally omitted <==

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b51(c). See Instruction 10.

Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response: 0.5

1. Name and Address of Reporting Person*
Hulls Chris
(Last)
(First)
(Middle)
C/O LIFE360, INC.
1900 SOUTH NORFOLK STREET, SUITE 310
(Street)
SAN MATEO
CA
94403
(City)
(State)
(Zip)		 2. Issuer NameandTicker or Trading Symbol
Life360, Inc. [
LIF]		 5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director
10% Owner
Officer (give title
below)
Other (specify
below)
3. Date of Earliest Transaction (Month/Day/Year)
09/01/2025
4. If Amendment, Date of Original Filed (Month/Day/Year) 6. Individual or Joint/Group Filing (Check Applicable
Line)
Form filed by One Reporting Person
Form filed by More than One Reporting
Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction
Date
(Month/Day/Year)		 2A. Deemed
Execution Date,
if any
(Month/Day/Year)		 3.
Transaction
Code (Instr.
8)		 4. Securities Acquired (A) or
Disposed Of (D) (Instr. 3, 4 and
5)		 5. Amount of
Securities
Beneficially
Owned Following
Reported
Transaction(s)
(Instr. 3 and 4)		 6. Ownership
Form: Direct
(D) or Indirect
(I) (Instr. 4)		 7. Nature of
Indirect
Beneficial
Ownership
(Instr. 4)
Code V Amount (A) or
(D)		 Price
Common Stock 09/01/2025 A
(1)		 26,499 A $ 0 483,830
(2)
(3)		 D
Common Stock 195,312
(4)		 I Held by
the Robin
Hulls 2023
Irrevocable
Trust
Common Stock 195,312
(4)		 I Held by
the Rose
Hulls 2023
Irrevocable
Trust
Common Stock 195,312
(4)		 I Held by
the
Mckenzie
Hulls 2023
Irrevocable
Trust
Common Stock 1,846
(5)		 I Held by
ICCA
Labs, LLC
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of
Derivative
Security
(Instr. 3)		 2.
Conversion
or Exercise
Price of
Derivative
Security		 3. Transaction
Date
(Month/Day/Year)		 3A. Deemed
Execution Date,
if any
(Month/Day/Year)		 4.
Transaction
Code (Instr.
8)		 5. Number
of
Derivative
Securities
Acquired
(A) or
Disposed
of (D)
(Instr. 3, 4
and 5)		 6. Date Exercisable and
Expiration Date
(Month/Day/Year)		 7. Title and
Amount of
Securities
Underlying
Derivative
Security (Instr.
3 and 4)		 8. Price of
Derivative
Security
(Instr. 5)		 9. Number of
derivative
Securities
Beneficially
Owned
Following
Reported
Transaction(s)
(Instr. 4)		 10.
Ownership
Form:
Direct (D)
or Indirect
(I) (Instr. 4)		 11. Nature
of Indirect
Beneficial
Ownership
(Instr. 4)
Code V (A) (D) Date
Exercisable		 Expiration
Date		 Title Amount
or
Number
of
Shares

Explanation of Responses:

  1. Represents the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. 1/48th of the RSUs will vest monthly from September 1, 2025, subject to the Reporting Person's continuous service through each vesting date.

  2. Includes 151,934 RSUs previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.

  3. Includes common stock and the number of shares of common stock underlying Chess Depositary Interests ("CDIs") as converted on a 1:3 common stock to CDI ratio. The CDIs are traded on the Australian Securities Exchange (the "ASX") and are held by CHESS Depositary Nominees Pty, Limited, a subsidiary of ASX Limited, the company that operates the ASX.

  4. Represents shares of the Issuer's common stock underlying 585,938 CDIs, which remain subject to a lock-up agreement.

  5. The Reporting Person is a member of ICCA Labs, LLC, an entity that holds an aggregate of 8,219 shares of the Issuer's common stock. The number of shares held as reported herein by the Reporting

Person represents his proportionate ownership interest in ICCA Labs, LLC.

  • /s/ Allison Chang, Attorney 09/03/2025 in-Fact ** Signature of Reporting Person Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

  • If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

SEC Form 4 FORM 4

Washington, D.C. 20549

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

OMB APPROVAL

==> picture [11 x 11] intentionally omitted <==

==> picture [11 x 11] intentionally omitted <==

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b51(c). See Instruction 10.

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB Number: 3235-0287 Estimated average burden hours per response: 0.5

for the purchase or sale of equity
securities of the issuer that is
intended to satisfy the affirmative
defense conditions of Rule 10b5-
1(c). See Instruction 10.		 for the purchase or sale of equity
securities of the issuer that is
intended to satisfy the affirmative
defense conditions of Rule 10b5-
1(c). See Instruction 10.		 for the purchase or sale of equity
securities of the issuer that is
intended to satisfy the affirmative
defense conditions of Rule 10b5-
1(c). See Instruction 10.		 for the purchase or sale of equity
securities of the issuer that is
intended to satisfy the affirmative
defense conditions of Rule 10b5-
1(c). See Instruction 10.		 for the purchase or sale of equity
securities of the issuer that is
intended to satisfy the affirmative
defense conditions of Rule 10b5-
1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Antonoff Lauren
(Last)
(First)
(Middle)
C/O LIFE360, INC.
1900 SOUTH NORFOLK STREET, SUITE 310
(Street)
SAN MATEO
CA
94403
(City)
(State)
(Zip)		 2. Issuer NameandTicker or Trading Symbol
Life360, Inc. [
LIF]		 5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director
10% Owner
Officer (give title
below)
Other (specify
below)
Chief Executive Officer
3. Date of Earliest Transaction (Month/Day/Year)
09/01/2025
4. If Amendment, Date of Original Filed (Month/Day/Year) 6. Individual or Joint/Group Filing (Check Applicable
Line)
Form filed by One Reporting Person
Form filed by More than One Reporting
Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction
Date
(Month/Day/Year)		 2A. Deemed
Execution Date,
if any
(Month/Day/Year)		 3.
Transaction
Code (Instr.
8)		 4. Securities Acquired (A) or
Disposed Of (D) (Instr. 3, 4 and
5)		 5. Amount of
Securities
Beneficially
Owned Following
Reported
Transaction(s)
(Instr. 3 and 4)		 6. Ownership
Form: Direct
(D) or Indirect
(I) (Instr. 4)		 7. Nature
of Indirect
Beneficial
Ownership
(Instr. 4)
Code V Amount (A) or
(D)		 Price
Common Stock 09/01/2025 A
(1)		 52,997 A $ 0 356,229
(2)		 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of
Derivative
Security
(Instr. 3)		 2.
Conversion
or Exercise
Price of
Derivative
Security		 3. Transaction
Date
(Month/Day/Year)		 3A. Deemed
Execution Date,
if any
(Month/Day/Year)		 4.
Transaction
Code (Instr.
8)		 5. Number
of
Derivative
Securities
Acquired
(A) or
Disposed
of (D)
(Instr. 3, 4
and 5)		 6. Date Exercisable and
Expiration Date
(Month/Day/Year)		 7. Title and
Amount of
Securities
Underlying
Derivative
Security (Instr.
3 and 4)		 8. Price of
Derivative
Security
(Instr. 5)		 9. Number of
derivative
Securities
Beneficially
Owned
Following
Reported
Transaction(s)
(Instr. 4)		 10.
Ownership
Form:
Direct (D)
or Indirect
(I) (Instr. 4)		 11. Nature
of Indirect
Beneficial
Ownership
(Instr. 4)
Code V (A) (D) Date
Exercisable		 Expiration
Date		 Title Amount
or
Number
of
Shares

Explanation of Responses:

  1. Represents the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. 1/48th of the RSUs will vest monthly from September 1, 2025, subject to the Reporting Person's continuous service through each vesting date.

  2. Includes 258,971 RSUs previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.

  3. /s/ Allison Chang, Attorney 09/03/2025 in-Fact ** Signature of Reporting Person Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

  • If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

  • ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

SEC Form 4 FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

==> picture [11 x 11] intentionally omitted <==

==> picture [11 x 11] intentionally omitted <==

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b51(c). See Instruction 10.

Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number: 3235-0287 Estimated average burden hours per response: 0.5

for the purchase or sale of equity
securities of the issuer that is
intended to satisfy the affirmative
defense conditions of Rule 10b5-
1(c). See Instruction 10.		 for the purchase or sale of equity
securities of the issuer that is
intended to satisfy the affirmative
defense conditions of Rule 10b5-
1(c). See Instruction 10.		 for the purchase or sale of equity
securities of the issuer that is
intended to satisfy the affirmative
defense conditions of Rule 10b5-
1(c). See Instruction 10.		 for the purchase or sale of equity
securities of the issuer that is
intended to satisfy the affirmative
defense conditions of Rule 10b5-
1(c). See Instruction 10.		 for the purchase or sale of equity
securities of the issuer that is
intended to satisfy the affirmative
defense conditions of Rule 10b5-
1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Goines Mark
(Last)
(First)
(Middle)
C/O LIFE360, INC.
1900 SOUTH NORFOLK STREET, SUITE 310
(Street)
SAN MATEO
CA
94403
(City)
(State)
(Zip)		 2. Issuer NameandTicker or Trading Symbol
Life360, Inc. [
LIF]		 5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director
10% Owner
Officer (give title
below)
Other (specify
below)
3. Date of Earliest Transaction (Month/Day/Year)
09/01/2025
4. If Amendment, Date of Original Filed (Month/Day/Year) 6. Individual or Joint/Group Filing (Check Applicable
Line)
Form filed by One Reporting Person
Form filed by More than One Reporting
Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction
Date
(Month/Day/Year)		 2A. Deemed
Execution Date,
if any
(Month/Day/Year)		 3.
Transaction
Code (Instr.
8)		 4. Securities Acquired (A) or
Disposed Of (D) (Instr. 3, 4 and
5)		 5. Amount of
Securities
Beneficially
Owned Following
Reported
Transaction(s)
(Instr. 3 and 4)		 6. Ownership
Form: Direct
(D) or Indirect
(I) (Instr. 4)		 7. Nature
of Indirect
Beneficial
Ownership
(Instr. 4)
Code V Amount (A) or
(D)		 Price
Common stock 09/01/2025 A
(1)		 189 A $ 0 6,070
(2)		 D
Common stock 71,809 I Held by
the
Goines
Wong
Living
Trust
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of
Derivative
Security
(Instr. 3)		 2.
Conversion
or Exercise
Price of
Derivative
Security		 3. Transaction
Date
(Month/Day/Year)		 3A. Deemed
Execution Date,
if any
(Month/Day/Year)		 4.
Transaction
Code (Instr.
8)		 5. Number
of
Derivative
Securities
Acquired
(A) or
Disposed
of (D)
(Instr. 3, 4
and 5)		 6. Date Exercisable and
Expiration Date
(Month/Day/Year)		 7. Title and
Amount of
Securities
Underlying
Derivative
Security (Instr.
3 and 4)		 8. Price of
Derivative
Security
(Instr. 5)		 9. Number of
derivative
Securities
Beneficially
Owned
Following
Reported
Transaction(s)
(Instr. 4)		 10.
Ownership
Form:
Direct (D)
or Indirect
(I) (Instr. 4)		 11. Nature
of Indirect
Beneficial
Ownership
(Instr. 4)
Code V (A) (D) Date
Exercisable		 Expiration
Date		 Title Amount
or
Number
of
Shares

Explanation of Responses:

  1. Represents the grant of Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. One-third (1/3) of the RSUs will vest on November 15, 2025, and the remaining two-thirds (2/3) will vest in equal quarterly installments thereafter, subject to the Reporting Person's continuous service through each vest date.

  2. Includes 3,055 RSUs previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.

/s/ Jay Sood, Attorney-in-Fact 09/03/2025

** Signature of Reporting Person Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

  • If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

  • ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

More from Life360, Inc.

Share Issue/Capital Change 2026
Jun 4
Director's Dealing 2026
Jun 3
Director's Dealing 2026
Jun 3
Director's Dealing 2026
Jun 3
Director's Dealing 2026
Jun 3
Director's Dealing 2026
Jun 3
Director's Dealing 2026
Jun 3
Director's Dealing 2026
Jun 3
Director's Dealing 2026
Jun 3
Director's Dealing 2026
Jun 2
View all filings →